Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives

Psychiatry Research

Volumn 208, Issue 2, 2013, Pages 118-124

  Lopez Garcia, Pilar ^a   Young Espinoza, Leslie ^b   Molero Santos, Patricio ^b   Marin, Juan ^b   Ortuño Sanchez Pedreño, Felipe ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

COMT; Context processing; DPX; Genetics; MATRICS; Neuropsychology

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; BRIEF PSYCHOTIC DISORDER; CATECHOL O METHYLTRANSFERASE GENE; COGNITION; CONTROLLED STUDY; DELUSIONAL DISORDER; DOPAMINERGIC ACTIVITY; DOT PATTERN EXPECTANCY TASK; FEMALE; FIRST DEGREE RELATIVE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT AND TREATMENT RESEARCH TO IMPROVE COGNITION IN SCHIZOPHRENIA CONSENSUS COGNITIVE BATTERY; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

ADULT; CATECHOL O-METHYLTRANSFERASE; COGNITION DISORDERS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84879415058     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.09.043     Document Type: Article

References (42)

1. Baddeley A.D. Working Memory 1986, Oxford University Press, New York, NY.
2. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald A., Noll D.C., Cohen J.D. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Archives of General Psychiatry 2001, 58:280-288.
3. Barch D.M., Carter C.S., MacDonald A.W., Braver T.S., Cohen J.D. Context processing deficits in schizophrenia: diagnostic specificity, four-week course, and relationships to clinical symptoms. Journal of Abnormal Psychology 2003, 112:132-143.
4. Barnett J.H., Scoriels L., Munafò M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biological Psychiatry 2008, 64(2):137-144.
5. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., Goldman R.S., Hoptman M.J., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., Kunz M., Chakos M., Cooper T.B., Lieberman J.A. Neurocognitive correlates of the COMT (Val158Met) polymorphism in chronic schizophrenia. Biological Psychiatry 2002, 52:701-707.
6. Blasi G., Mattay V.S., Bertolino A., Bertolino A., Elvevåg B., Callicott J.H., Das S., Kolachana B.S., Egan M.F., Goldberg T.E., Weinberger D.R. Effect of catechol-O-methyltransferase Val158Met genotype on attentional control. Journal of Neuroscience 2005, 25:5038-5045.
7. Bowie C.R., Reichenberg A., Patterson T.L., Patterson T.L., Heaton R.K., Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. American Journal of Psychiatry 2006, 163(3):418-425.
8. Bruder G.E., Keilp J.G., Xu H., Shikhman M., Schori E., Gorman J.M., Gilliam T.C. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biological Psychiatry 2005, 58:901-907.
9. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics 2004, 75:807-821.
10. Cohen J.D., Servan-Schreiber D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychological Review 1992, 99(1):45-77.
11. Cohen J.D., Barch D.M., Carter C.S, Servan-Schreiber D. Context processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. Journal of Abnormal Psychology 1999, 108:120-133.
12. Delawalla Z., Csernansky J.G., Barch D.M. Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biological Psychiatry 2008, 63(5):490-497.
13. Diaz-Asper C.M., Goldberg T.E., Kolachana B.S., Straub R.E., Egan M.F., Weinberger D.R. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biological Psychiatry 2008, 63:72-79.
14. Dickinson D., Elvevåg B. Genes, cognition and brain through a COMT lens. Neuroscience 2009, 164(1):72-87.
15. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(12):6917-6922.
16. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry 2003, 160:469-476.
17. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., Goldman D., Weinberger D.R. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry 2003, 60(9):889-896.
18. Goldman D., Weinberger D.R., Malhotra A.K., Goldberg T.E. The role of COMT Val158Met in cognition. Biological Psychiatry 2009, 65(1):e1-2.
19. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophrenia Bulletin 2000, 26(1):119-136.
20. Green A.E., Munafo M.R., Deyoung C.G., Fossella J.A., Fan J., Gray J.R. Using genetic data in cognitive neuroscience: from growing pains to genuine insights. Nature Review Neurosciences 2008, 9:710-720.
21. Ho B.C., Wassink T.H., O'Leary D.S., Sheffield V.C., Andreasen N.C. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Molecular Psychiatry 2005, 10(229):287-298.
22. Javitt D.C., Shelley A.M., Silipo G., Lieberman J.A. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Archives of General Psychiatry 2000, 57:1131-1137.
23. Jones A.H., Sponheim S.R., MacDonald A.W. The dot pattern expectancy task: reliability and replication of deficits in schizophrenia. Psychological Assessesment 2010, 22:131-141.
24. Joober R., Gauthier J., Lal S.., Bloom D., Lalonde P., Rouleau G., Benkelfat C., Labelle A. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Archives of General Psychiatry 2002, 59(7):662-663.
25. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
26. Leung W.W., McClure M.M., Siever L.J., Barch D.M., Harvey P.D. Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions. Journal of Neuropsychiatric Disease and Treatment 2007, 3(6):925-934.
27. Liao S.Y., Lin S.H., Liu C.M., Hsieh M.H., Hwang T.J., Liu S.K., Guo S.C., Hwu H.G., Chen W.J. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia. Genes, Brain and Behavior 2009, 8:228-237.
28. MacDonald A.W., Carter C.S. Event-related fMRI study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. Journal of Abnormal Psychology 2003, 112(4):689-697.
29. MacDonald A.W., Pogue-Geile M.F., Johnson M.K., Carter C.S. A specific deficit in context processing in the unaffected siblings of patients with schizophrenia. Archives of General Psychiatry 2003, 60:57-65.
30. MacDonald A.W., Goghari V.M., Hicks B.M., Flory J.D., Carter C.S., Manuck S.B. A convergent-divergent approach to context processing, general intellectual functioning, and the genetic liability to schizophrenia. Neuropsychology 2005, 19(6):814-821.
31. MacDonald A.W., Carter C.S., Flory J.D., Ferrell R.E., Manuck S.B. COMT Val158Met and executive control: a test of the benefit of specific deficits to translational research. Journal of Abnormal Psychology 2007, 116(2):306-312.
32. MacDonald A.W. Building a clinically relevant cognitive task: case study of the AX paradigm. Schizophrenia Bulletin 2008, 34:619-628.
33. Mata I., Perez-Iglesias R., Pelayo-Teran J.M., Rodríguez-Sanchez J.M., Gonzalez-Blanch C., Carrasco-Marin E, Vazquez-Barquero J.L., Crespo-Facorro B. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis. Schizophrenia Research 2008, 102:206-209.
34. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., Callicott j.H., Weinberger D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6186-6191.
35. Papaleo F., Crawley J.N., Song J., Lipska B.K., Pickel J., Weinberger D.R., Chen J. Genetic dissection of the role of catechol-O-methyltransferase (COMT) in cognition and stress reactivity in mice. Journal of Neuroscience 2008, 28:8709-8723.
36. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martinez-Larrea A, Fañanás L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. American Journal of Psychiatry 2004, 161:1110-1112.
37. Servan-Schreiber D., Cohen J.D., Steingard S. Schizophrenic deficits in the processing of context: a test of a theoretical model. Archives of General Psychiatry 1996, 53:1105-1113.
38. Stefanis N.C., Van Os J., Avramopoulos D., Smyrnis N., Evdokimidis I., Hantoumi I., Stefanis C.N. Variation in catechol-O methyltransferase Val158Met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biological Psychiatry 2004, 56:510-515.
39. Stratta P., Daneluzzo E., Bustini M., Casacchia M., Rossi A. Schizophrenia deficits in the processing of context. Archives of General Psychiatry 1998, 55:186-187.
40. Tsai S.J., Yu Y.W., Chen T.J., Chen J.Y., Liou Y.J., Chen M.C., Hong C.J. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neuroscience Letters 2003, 338:123-126.
41. Tunbridge E.M., Harrison P.J., Weinberger D.R. Catechol-o-Methyltransferease, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry 2006, 60(2):141-151.
42. Wirgenes K.V., Djurovic S., Sundet K., Agartz I., Mattingsdal M., Athanasiu L., Melle I., Andreassen O.A. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophrenia Research 2010, 122:31-37.